FOLH1 and neoplasm: In an attempt to achieve higher tumor uptake than observed with [177Lu]Lu-PSMA-617, but faster clearance from the blood as compared to that of [177Lu]Lu-PSMA-ALB-56, a series of novel PSMA ligands were developed with ibuprofen as an albumin-binding entity conjugated via variable linker entities [19].